Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Rule 8.3- Omega Diagnostics Group Plc

21 Oct 2009 10:50

RNS Number : 1464B
Henderson Global Investors Ltd
21 October 2009
Β 

FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

Β 

1. KEY INFORMATION

Name of person dealing (Note 1)

HendersonΒ Global Investors Ltd

Company dealt in

Omega Diagnostics Group Plc

Class of relevant security to which the dealings being disclosed relateΒ (Note 2)

Ord 4p

Date of dealing

20/10/2009

Β 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

Β 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt inΒ (Note 3)

Β 

Β 

Long

Short

Β 

NumberΒ 

(%)

Number

(%)

(1) Relevant securitiesΒ 

541,666

2.6252

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

541,666

2.6252

Β 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt inΒ (Note 3)

Β Class of relevant security:

Long

Short

Β 

Number

(%)

Number

(%)

(1) Relevant securitiesΒ 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

Β 

(c) Rights to subscribeΒ (Note 3)

Β 

Class of relevant security:

Details

3. DEALINGSΒ (Note 4)

Β 

(a) Purchases and sales

Β 

Purchase/sale

Number of securities

Price per unit (Note 5)

Sale

50,000

0.35GBP

Β 

(b) Derivatives transactions (other than options)

Β 

Product name, e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Β 

Product name,e.g. call optionΒ 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise priceΒ 

Type, e.g. American, European etc.

Expiry date

Option moneypaid/received per unit (Note 5)Β 

Β 

Β 

(ii) Exercising

Β 

Product name, e.g. call option

Number of securitiesΒ 

Exercise price per unit (Note 5)

Β 

(d) Other dealings (including new securities)Β (Note 4)

Β 

Nature of transaction (Note 8)Β 

Details

Price per unit (if applicable)Β (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

……………………………………………………………………

……………………………………………………………………

Is a Supplemental Form 8 attached?Β (Note 9) No

Β 

Β 

Date of disclosure

21/10/2009

Contact name

Gavin Dolding

Telephone number

020 7818Β 5217

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website atΒ www.thetakeoverpanel.org.uk

SUPPLEMENTAL FORM 8

Β 

Β 

DETAILS OF OPEN POSITIONSΒ 

(This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate)

Β 

Β 

Β 

Β 

OPEN POSITIONSΒ (Note 1)

Β 

Product name,e.g. call option

Β 

Written or purchased

Β 

Number of securities to which the option or derivative relates

Exercise priceΒ (Note 2)

Β 

Type, e.g. American, European etc.

Expiry date

Β 

Notes

Β 

1. Where there are open option positions or open derivative positions (except for CFDs), full details shouldΒ be given. Full details of anyΒ existing agreements to purchase or to sellΒ should also be given on this form.

Β 

2. For all prices and other monetary amounts, the currency must be stated.

Β 

For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website atΒ www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RETKGMZGLMGGLZG
Date   Source Headline
6th Sep 20237:00 amRNSAGM Statement
1st Sep 202310:29 amRNSUpdate on proposed Share Reorganisation
31st Aug 20237:00 amRNSProposed Share Reorganisation Timetable
22nd Aug 20237:00 amRNSDirectorate Change
17th Aug 20237:00 amRNSBoard Appointment
15th Aug 20231:45 pmRNSDirector/PDMR Shareholding
14th Aug 20237:00 amRNSPosting of Annual Report and confirmation of AGM
3rd Aug 20237:00 amRNSFinal Results
27th Jul 20237:00 amRNSNotice of Results
26th Jul 20232:10 pmRNSHolding(s) in Company
6th Jun 202311:19 amRNSHolding(s) in Company
5th Jun 20234:51 pmRNSHolding(s) in Company
2nd Jun 20232:45 pmRNSHolding(s) in Company
22nd May 20235:33 pmRNSHolding(s) in Company
10th May 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th May 20233:42 pmRNSDirector/PDMR Shareholding
21st Apr 20239:48 amRNSHolding(s) in Company
19th Apr 20239:31 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update
22nd Mar 20235:57 pmRNSBlock Listing Six Monthly Return
22nd Mar 20233:00 pmRNSHolding(s) in Company
6th Mar 20232:31 pmRNSHolding(s) in Company
27th Jan 20233:03 pmRNSHolding(s) in Company
27th Jan 20239:36 amRNSDirector/PDMR Shareholding
18th Jan 20237:00 amRNSTrading update
16th Jan 202310:56 amRNSHolding(s) in Company
6th Jan 20237:00 amRNSUS expansion update
3rd Jan 202312:34 pmRNSHolding(s) in Company
13th Dec 20224:40 pmRNSSecond Price Monitoring Extn
13th Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 202212:01 pmRNSHolding(s) in Company
30th Nov 20229:35 amRNSHolding(s) in Company
25th Nov 20227:00 amRNSReceipt of deferred consideration
24th Nov 20227:00 amRNSHalf-year Report
23rd Nov 20224:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
23rd Nov 20222:05 pmRNSSecond Price Monitoring Extn
23rd Nov 20222:00 pmRNSPrice Monitoring Extension
18th Nov 202212:09 pmRNSHolding(s) in Company
16th Nov 20222:06 pmRNSSecond Price Monitoring Extn
16th Nov 20222:00 pmRNSPrice Monitoring Extension
15th Nov 20227:00 amRNSConfirmation of Results and Investor Presentation
14th Nov 20227:00 amRNSPartnership agreement with Software Provider
8th Nov 20229:04 amRNSLaunch of new all-employee share incentive plan
26th Oct 20222:50 pmRNSResult of AGM
26th Oct 20227:00 amRNSAGM Statement and Notice of Results
11th Oct 20227:00 amRNSScientific Director to present at FIDHC
5th Oct 20227:00 amRNSPositive WHO data received for VISITECT® CD4 test
27th Sep 20227:00 amRNSPosting of Annual Report and confirmation of AGM
20th Sep 202212:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.